Pressemitteilung BoxID: 439010 (Oasmia Pharmaceutical AB)
  • Oasmia Pharmaceutical AB
  • Vallongatan 1
  • SE-752 2 Uppsala
  • Ansprechpartner
  • Maria Lundén
  • +46 (185) 054-40

Oasmia and Orion Corporation jointly end Paclical® agreement

(PresseBox) (Uppsala, ) Oasmia Pharmaceutical AB and Orion Corporation jointly agreed to end the agreement regarding distribution of Paclical® in the Nordic region. The cooperation is ended without any further obligations from either part. The distribution rights for the Nordic region returns to Oasmia and enhances flexibility regarding the European market.